Iris Dorbian
Invixium, a Toronto-based maker of biometric solutions for access control and workforce digitalization, has raised C$3 million in new financing.
Canadian life sciences venture capital firm AmorChem has invested in a McGill University project focused on the identification of small molecules to treat an aggressive form of ovarian cancer.
K8 Ventures has hired Dmitry Valbe to lead technology development.
VMWare has agreed to acquire cybersecurity company and breach detection platform Lastline, according to a blog post.
Applied Molecular Transport, a biopharmaceutical company, has raised $154 million for its IPO after pricing its 11 million shares at $14 per share.
Cloud9 Technologies, a provider of cloud-based communications, has closed $17.5 million in Series B funding.
Charlotte, North Carolina-based Atom Power, a digital circuit breaker inventor, has raised $17.75 million in Series B funding.
Hyperscience, an automation platform, has raised $60 million in Series C funding, according to a blog post on the site.
Prilenia Therapeutics B.V., a developer of novel treatments for neurodegenerative and neurodevelopmental disorders, has raised $62.5 million in Series A financing.
Everest Medicines, a biopharmaceutical company, has raised $310 million in Series C financing.